Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis
- 1 July 2013
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 12 (4) , 384-389
Abstract
No abstract availableKeywords
Funding Information
- NIH/NIDCD (R01 DC 011818)
This publication has 28 references indexed in Scilit:
- The roles of biofilm matrix polysaccharide Psl in mucoidPseudomonas aeruginosabiofilmsFEMS Immunology & Medical Microbiology, 2012
- Evolution and Adaptation in Pseudomonas aeruginosa Biofilms Driven by Mismatch Repair System-Deficient MutatorsPLOS ONE, 2011
- The Pseudomonas aeruginosa opportunistic pathogen and human infectionsEnvironmental Microbiology, 2011
- Trends in the use of routine therapies in cystic fibrosis: 1995-2005Pediatric Pulmonology, 2010
- The biofilm matrixNature Reviews Microbiology, 2010
- Measuring and improving respiratory outcomes in cystic fibrosis lung disease: Opportunities and challenges to therapyJournal of Cystic Fibrosis, 2010
- Improvements in Lung Function Outcomes in Children with Cystic Fibrosis are Associated with Better Nutrition, Fewer Chronic Pseudomonas aeruginosa Infections, and Dornase Alfa UseThe Journal of Pediatrics, 2008
- IHF and HU: flexible architects of bent DNACurrent Opinion in Structural Biology, 2004
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994